Stockreport

Corcept's Phase III trial of ovarian cancer therapy shows PFS improvement [Yahoo! Finance]

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors
PDF an improvement in progression-free survival (PFS) in individuals with platinum-resistant ovarian cancer. The trial, which enrolled 381 platinum-resistant ovarian cance [Read more]